z-logo
open-access-imgOpen Access
Proton Pump Inhibitors versus Solitary Lifestyle Modification in Management of Laryngopharyngeal Reflux and Evaluating who is at Risk: Scenario in a Developing Country
Author(s) -
Chappity Preetam,
Rakesh Kumar,
Ramesh Chandra Deka,
Venkatakarthikeyan Chokkalingam,
Anoop Saraya,
Kapil Sikka
Publication year - 2014
Publication title -
clinical medicine insights ear nose and throat
Language(s) - English
Resource type - Journals
ISSN - 1179-5506
DOI - 10.4137/cment.s13799
Subject(s) - laryngopharyngeal reflux , medicine , population , proton pump inhibitor , disease , malignancy , randomized controlled trial , intensive care medicine , randomization , reflux , surgery , environmental health
Laryngopharyngeal reflux disease can present with a varied symptomatology because of the involvement of multiple sub-sites of the upper aero-digestive tract. It is a very common disease to be encountered in routine practice by both medical and ENT personnel. Its association with multiple pathologies including malignancy warrants an early diagnosis and management. The lack of cost effective and non-invasive tests constitutes a major hurdle in its early management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom